H-SPAN Summit D.C. 2026 | Translating Geroscience from Lab to Patients

Moderator: Hanadie Yousef Panelists: Stephen Kritchevsky, David Gobel, Matt Kaeberlein The geroscience hypothesis has strong support in animal models and a growing body of human data. Getting from there to an approved therapy is a different problem, involving trial design, endpoint selection, regulatory strategy, and money. This panel covers what the field has learned from clinical efforts so far, including the long road of the TAME trial, how a trial targeting aging can be structured to satisfy the FDA, and what should be prioritized to get a first intervention across the finish line.